CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 

China Biologic Products Holdings Inc 's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Total Assets Change -1.63 % -1.63 % -1.63 % -1.63 % 143.5 %
Y / Y Net Income Change 10.43 % - - - 79.93 %
Net Income (TTM) in Millions 163 148 148 148 148
Return On Assets (TTM) 8.43 % 7.6 % 7.57 % 7.54 % 7.51 %
Total Ranking # 732 # # # # 912
Total Assets (TTM) in Millions 1,938 1,938 1,938 1,938 1,970
Seq. Total Assets Change 0 % 0 % 0 % -1.63 % 0 %
Seq. Net Income Change 0 % - - - 0 %


Roa Comment
China Biologic Products Holdings Inc yielded Return on Asset in IV. Quarter below company average, at 8.43 %.

ROA improved compare to previous quarter, due to net income growth.

Within Healthcare sector 100 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from to 732.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 101
Overall # 719

Return On Assets Statistics
High Average Low
23.95 %
19.37 %
7.36 %
(June 30. 2015)   (Dec 31 2018)


Financial Statements
China Biologic Products Holdings Inc 's Assets $ 1,938 Millions CBPO's Balance sheet
China Biologic Products Holdings Inc 's Income $ 163 Millions Quarterly CBPO's Income Statement
CBPO's Income by Division See CBPO's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
(Dec 31 2015)
FY 2015
Y / Y Total Assets Change -1.63 % 143.5 % 44.03 % 9.79 % 14.5 %
Total Assets in Millions 1,938 1,970 809 562 512
Y / Y Net Income Change 10.43 % 79.93 % -36.15 % 12.87 % 18.72 %
Net Income in Millions 163 148 82 129 114
Return On Assets 8.43 % 7.51 % 10.16 % 22.93 % 22.3 %




Roa Comment
In the fiscal year 2019 ROA improved to 8.43 % compare to previous year, due to annual net income growth of 10.43 % to $163.40 millions, and due to decline of value in China Biologic Products Holdings Inc 's assets by -1.63 % to $1,937.86 millions, compare to $1,937.86 a year before.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CBPO's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for CBPO's Competitors
Roa for China Biologic Products Holdings Inc 's Suppliers
Return On Asstes for CBPO's Customers

You may also want to know
CBPO's Roi CBPO's Inventory Turnover Ratio CBPO's Growth Rates CBPO's Dividend Comparisons
CBPO's Profitability Ratios CBPO's Asset Turnover Ratio CBPO's Dividend Growth
CBPO's Roe CBPO's Valuation Ratios CBPO's Financial Strength Ratios CBPO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2019, within Healthcare Sector ROA
Biogen Inc.  21.92 %
Abiomed Inc.  21.79 %
Eli Lilly And Company  21.63 %
Lifevantage Corp  21.33 %
Biospecifics Technologies Corp  21.14 %
Aveo Pharmaceuticals Inc.  21.03 %
Mettler Toledo International Inc  20.93 %
Chemed Corporation  18.86 %
Align Technology inc.  18.78 %
Exelixis Inc.  18.73 %
Boston Scientific Corporation  17.83 %
Edwards Lifesciences Corporation  17.82 %
Alpha Pro Tech Ltd.  17.68 %
Petmed Express Inc.  17.14 %
Iradimed Corporation  16.01 %
Vertex Pharmaceuticals Inc  16.01 %
Alexion Pharmaceuticals Inc   15.78 %
Intuitive Surgical Inc.  15.51 %
Regeneron Pharmaceuticals Inc.  15.45 %
Masimo Corp  15.33 %
Fonar Corporation  15.01 %
Pro dex Inc.  14.74 %
Atrion Corporation  14.58 %
Horizon Therapeutics Public Limited Company  14.51 %
Incyte Corp  14.48 %
Sinovac Biotech Ltd  14.42 %
Summit Therapeutics Inc.  13.96 %
Utah Medical Products Inc  13.95 %
Illumina Inc.  13.77 %
Zoetis Inc.  13.43 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRNA's Profile

Stock Price

GRNA's Financials

Business Description

Fundamentals

Charts & Quotes

GRNA's News

Suppliers

GRNA's Competitors

Customers & Markets

Economic Indicators

GRNA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071